Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine.
Dias Assis BR, Gomes IP, de Castro JT, Rivelli GG, de Castro NS, Gomez-Mendoza DP, Bagno FF, Hojo-Souza NS, Chaves Maia AL, Lages EB, da Fonseca FG, Ribeiro Teixeira SM, Fernandes AP, Gazzinelli RT, Castro Goulart GA. Dias Assis BR, et al. Among authors: gazzinelli rt. Nanomedicine (Lond). 2023 Aug;18(18):1175-1194. doi: 10.2217/nnm-2023-0122. Epub 2023 Sep 15. Nanomedicine (Lond). 2023. PMID: 37712604 Clinical Trial.
Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
Coelho EA, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, Rodrigues RC, Charest H, Matlashewski G, Gazzinelli RT, Fernandes AP. Coelho EA, et al. Among authors: gazzinelli rt. Infect Immun. 2003 Jul;71(7):3988-94. doi: 10.1128/IAI.71.7.3988-3994.2003. Infect Immun. 2003. PMID: 12819086 Free PMC article.
Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections.
Zanin FH, Coelho EA, Tavares CA, Marques-da-Silva EA, Silva Costa MM, Rezende SA, Gazzinelli RT, Fernandes AP. Zanin FH, et al. Among authors: gazzinelli rt. Microbes Infect. 2007 Jul;9(9):1070-7. doi: 10.1016/j.micinf.2007.05.012. Epub 2007 May 16. Microbes Infect. 2007. PMID: 17644455 Free article.
Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells.
Resende DM, Caetano BC, Dutra MS, Penido ML, Abrantes CF, Verly RM, Resende JM, Piló-Veloso D, Rezende SA, Bruna-Romero O, Fernandes AP, Gazzinelli RT. Resende DM, et al. Among authors: gazzinelli rt. Vaccine. 2008 Aug 18;26(35):4585-93. doi: 10.1016/j.vaccine.2008.05.091. Epub 2008 Jun 25. Vaccine. 2008. PMID: 18588933
Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population.
Testasicca MC, dos Santos MS, Machado LM, Serufo AV, Doro D, Avelar D, Tibúrcio AM, Abrantes Cde F, Machado-Coelho GL, Grimaldi G Jr, Gazzinelli RT, Fernandes AP. Testasicca MC, et al. Among authors: gazzinelli rt. Vet Parasitol. 2014 Aug 29;204(3-4):169-76. doi: 10.1016/j.vetpar.2014.04.025. Epub 2014 May 2. Vet Parasitol. 2014. PMID: 24863572
New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent Trypanosoma cruzi CL-14 Strain Are Highly Antigenic and Protective against Leishmania infantum Challenge.
Almeida APMM, Machado LFM, Doro D, Nascimento FC, Damasceno L, Gazzinelli RT, Fernandes AP, Junqueira C. Almeida APMM, et al. Among authors: gazzinelli rt. Front Immunol. 2018 Mar 15;9:465. doi: 10.3389/fimmu.2018.00465. eCollection 2018. Front Immunol. 2018. PMID: 29599776 Free PMC article.
308 results